Nano Dimension Ltd. — Regulatory Filings 2016

May 25, 2016

6-K 1 f6k052516_nanodimension.htm REPORT OF FOREIGN PRIVATE ISSUER

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of: May 2016 (Report No. 3)

Commission file number: 001-37600

NANO DIMENSION LTD.

(Translation of registrant's name into English)

2 Ilan Ramon

Ness Ziona 7403635 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CONTENTS

Attached hereto and incorporated by reference herein is the Registrant's press release issued on May 25, 2016, announcing successful bioprinting trial of stem cell-derived tissues, in collaboration with Accellta Ltd.

Exhibit No.

99.1 Press release issued by Nano Dimension Ltd. on May 25, 2016, announcing successful bioprinting trial of stem cell-derived tissues, in collaboration with Accellta Ltd.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Nano
Dimension Ltd. (Registrant) | |
| --- | --- |
| By: | /s/
Amit Dror |
| Name: | Amit
Dror |
| Title : | Chief
Executive Officer |

Date: May 25, 2016

3

Field: Rule-Page

Field: /Rule-Page